Latest Breaking News On - Kineta inc - Page 8 : comparemela.com

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThierry guillaudeuxKineta incJacques bouchyevp investor relations business developmentJohn mullalylifesci advisorsAnnual macrophage directed therapies summitChief scientific officerEngineered iggCombination with pembrolizumabAdvanced solid tumorspresenterBusiness development

Kineta (NASDAQ:KA) Announces Quarterly Earnings Results

Kineta (NASDAQ:KA – Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.46) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.09, reports. Kineta Stock Up 5.7 % Shares of KA traded up $0.24 during trading hours on Monday, hitting $4.42. 44,832 shares of the […]

Blackrock incKineta incColony groupAsset management incRenaissance technologiesGeode capital managementGet free reportCapital managementManagement incKineta dailyNasdaq ka

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shawn iadonatoThierry guillaudeuxJacques bouchyevp investor relations business developmentSociety for immunotherapy of cancerKineta incSan diego convention centerJohn mullalylifesci advisorsFavorable clinical safetyTolerability profile observedCombination therapy clinical data anticipatedChief scientific officerChief executive officerAbstract numberTime locationExhibit hallsDiego convention

Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Shawn iadonatoJacques bouchyJohn mullalySociety for immunotherapy of cancerResearch collaboration agreementKineta incFred hutchinson cancer centerSlab programLifesci advisorsInvestor relations business developmentReports third quarterProvides corporateCash runwayChief executive officerGuillaudeux phdChief scientific officer

Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting

Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jacques bouchyThierry guillaudeuxJohn mullalySociety for immunotherapy of cancerLifesci advisorsKineta incSan diego convention centerInvestor relations business developmentPresents new preclinical dataAntibody showed high binding affinityStrongt cell activationVivo antitumor efficacySingle agentCheckpoint inhibitorsHematological tumorChief scientific officer